ExLibris header image
 

SFX by Ex Libris Inc.

Contains information about title and source of a journal
Naslov: P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB OR ZANUBRUTINIB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): RESULTS FROM A MULTI-ARM PHASE 1B STUDY
Vir:

Hemasphere [2572-9241] Soumerai, J D l. 2022, letn. 6, str. 1004 -1005

List of services to meet your request

Contains list of services for current record

Basic services

Celotno besedilo


service type icon, opens target in new window
 
 

service type icon, opens target in new window
 
 

service type icon, opens target in new window
 
 

service type icon, opens target in new window
 
 
  Dostopnost: Dostop je mogoč iz prostorov Univerze na Primorskem.

Celotno besedilo


service type icon, opens target in new window


© 2024 SFX by Ex Libris Inc. | Piškotki
CrossRef Omogočeno